Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Oncoimmunology|February 17, 2025
Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responsesRita Turpin, Karita Peltonen, Jenna H Rannikko, et al.Psycho-Oncology|October 13, 2023
Well-being trajectories in breast cancer and their predictors: A machine-learning approachEvangelos C Karademas, Eugenia Mylona, Ketti Mazzocco, et al.Journal for Immunotherapy of Cancer|April 11, 2024
Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironmentRita Turpin, Ruixian Liu, Pauliina M Munne, et al.JMIR Research Protocols|October 12, 2022
Predicting Effective Adaptation to Breast Cancer to Help Women BOUNCE Back: Protocol for a Multicenter Clinical Pilot StudyGreta Pettini, Virginia Sanchini, Ruth Pat-Horenczyk, et al.Nature Communications|February 22, 2019
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapyHeidi M Haikala, Johanna M Anttila, Elsa Marques, et al.Nature Communications|February 8, 2019
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapyHeidi M Haikala, Johanna M Anttila, Elsa Marques, et al.Nature Communications|November 30, 2021
Compressive stress-mediated p38 activation required for ERα + phenotype in breast cancerPauliina M Munne, Lahja Martikainen, Iiris Räty, et al.Cell Reports|July 3, 2026
Complex I drives glutamine-dependent TCA cycle to support viability of MYChigh breast cancer cellsJohanna M Anttila, Mariel Savelius, Linda Id, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2020
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA TrialCristina Saura, Mafalda Oliveira, Yin-Hsun Feng, et al.Journal of the National Cancer Institute|August 14, 2020
Common Susceptibility Loci for Male Breast CancerSarah Maguire, Eleni Perraki, Katarzyna Tomczyk, et al.Pageof 6